Using a bioink made from alginate and human cells, researchers at the Technical University (TU) Berlin and other institutions have printed a three-dimensional model of a cancer metastasis in healthy tissue. They used a commercially available bio-printer for this purpose, so that the tumor m ... more
Dipl. Ing. Sonja Jost
Technische Universität Berlin, DexLeChem GmbH
born in 1980, studied Industrial Engineering / Technical Chemistry at the Berlin University of Technology. From 2006 to 2011, she received various research fellowships in the field of homogeneous chiral catalysis. From 2011 to 2012, she was the project manager of a project receiving third-party funding on the subject of “catalyst re-using” at the Berlin University of Technology (EXIST research transfer), from which she founded DexLeChem GmbH together with four other co-partners at the beginning of 2013. She is the CEO. DexLeChem has been a partner in the Unifying Concepts in Catalysis (UniCat) cluster of excellence since the summer of 2013, and has been honoured by the Science4Life start-up initiative, amongst others. The interdisciplinary R&D team (theoretical physics, catalysis, process engineering) around Jost specializes in homogeneous chiral catalysis processes.